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Safe and efficient gene transfer systems are the basis of gene therapy applications. Non-integrating lentiviral (NIL) vectors are 
among the most promising candidates for gene transfer tools, because they exhibit high transfer efficiency in both dividing and 
non-dividing cells and do not present a risk of insertional mutagenesis. However, non-integrating lentiviral vectors cannot in-
troduce stable exogenous gene expression to dividing cells, thereby limiting their application. Here, we report the design of a 
non-integrating lentiviral vector that contains the minimal scaffold/matrix attachment region (S/MAR) sequence (SNIL), and 
this SNIL vector is able to retain episomal transgene expression in dividing cells. Using SNIL vectors, we detected the expres-
sion of the eGFP gene for 61 days in SNIL-transduced stable CHO cells, either with selection or not. In the NIL group without 
the S/MAR sequence, however, the transduced cells died under selection for the transient expression of NIL vectors. Further-
more, Southern blot assays demonstrated that the SNIL vectors were retained extrachromosomally in the CHO cells. In con-
clusion, the minimal S/MAR sequence retained the non-integrating lentiviral vectors in dividing cells, which indicates that 
SNIL vectors have the potential for use as a gene transfer tool. 
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Gene therapy involves introducing a therapeutic gene/RNA 
into a target cell/tissue to restore deficient protein function 
caused by a genetic disorder (Kootstra and Verma, 2003; 
Verma and Weitzman, 2005). Although many factors influ-
ence this process, the success of gene therapy relies consid-
erably on the selection of an appropriate gene delivery sys-
tem. An ideal gene delivery system should be capable of 
efficient gene transfer in various cell types without produc-
ing a pathogenic effect (Kootstra and Verma, 2003).  
Human immunodeficiency virus (HIV)-based lentiviral 
vectors have been accepted as efficient gene transfer tools 
because they have a relatively large packaging capacity, 
broad cell tropism, specific cell-type targeting, weak im-
munogenesis and are easily produced (Abordo-Adesida et 
al., 2005; Cronin et al., 2005; Kafri et al., 1997). Most im-
portantly, lentiviral vectors have the unique advantage of 
being able to stably transduce both dividing and non-   
dividing cells (Naldini, 1998; Naldini et al., 1996). Howev-
er, similar to other integrating systems, the integrating fea-
ture of lentiviral vectors can cause unbalanced gene expres-
sion and gene silencing and might even present risks of in-
sertional mutagenesis, which can lead to serious effects, 
such as malignant transformation (Kohn et al., 2003).   
Alternatively, because non-integrating lentiviral (NIL) 
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vectors do not integrate into the host genome, they avoid 
these problems while harnessing the positive attributes as-
sociated with lentiviral gene transfer. Therefore, NIL vec-
tors have been demonstrated to be an efficient and safe gene 
delivery system (Kohn et al., 2003), and they are useful in 
gene therapy applications (Yáñez-Muñoz et al., 2006). 
However, NIL vectors have a critical shortcoming—in di-
viding cells, the vector DNA is rapidly lost during cell divi-
sion, which results in a reduction or even a loss of transgene 
expression (Nightingale et al., 2006). Once lentiviral vectors 
enter host cells, linear vector DNA molecules are formed 
from the reverse transcription of the vector genomes. These 
linear molecules then serve as substrates for viral integra-
tion (Brown et al., 1989). As by-products of this process, 
two types of circular DNA molecules (1-LTR circles and 
2-LTR circles) are created from the linear DNA through the 
recombination of viral LTRs (Cara and Reitz, 1997; Pang et 
al., 1990; Pauza et al., 1990; Robinson and Zinkus, 1990). 
These circular LTR episomes are actively transcribed and 
accumulate in the cells transduced with NIL vectors, there-
by resulting in efficient and prolonged transgene expression 
in post-mitotic tissues (Panganiban and Temin, 1983; Saenz 
et al., 2004; Stevenson et al., 1990; Wu, 2004). However, 
because these LTR circles lack an origin of replication (ori), 
they cannot self-propagate during cell division and are 
eventually lost in dividing cells (Apolonia et al., 2007; 
Butler et al., 2002; Pierson et al., 2002). Thus, NIL vectors 
introduce only transient gene expression in dividing cells. 
Heterologous elements have been incorporated into NIL 
vectors to facilitate the nuclear retention and replication of 
the vectors in dividing cells, such as the ori sequence of 
Epstein-Barr or Simian viruses (Vargas et al., 2008). The ori 
sequences from viral genomes do provide episomal persis-
tence but also introduce safety problems, such as the poten-
tial risk of immunogenesis or transformation (Moens et al., 
1997; Slinskey et al., 1999; Wang and Sugden, 2005).  
In mammalian genomes, there are types of DNA ele-
ments that interact with elements in the nuclear matrix to 
separate the chromosome into specific spatial domains and 
modulate temporal DNA replication and gene expression 
during cell cycles (Hagedorn et al., 2011; Mirkovitch et al., 
1984). Scaffold/matrix attachment regions (S/MARs) are 
types of functional DNA elements that are ubiquitously 
present in eukaryotic genomes. S/MAR sequences promote 
episomal maintenance and replication (Jackson et al., 2006; 
Piechaczek et al., 1999), prevent epigenetic silencing (Jenke 
et al., 2004a), and promote transgene expression (Jenke et 
al., 2002). Episomal vectors based on the S/MAR sequence 
from the human -interferon locus can stably retain ex-
trachromosomal expression for several hundreds of genera-
tions after exposure to an initial selective pressure in vitro in 
CHO-K1 (Piechaczek et al., 1999), HeLa (Schaarschmidt et 
al., 2004) and K562 cells (Papapetrou et al., 2005). Moreo-
ver, the episomal maintenance and replication features of 
these vectors have also been demonstrated in primary hu-
man cells (human cord blood CD34+ cells (Papapetrou et 
al., 2006)) and in vivo (liver). S/MAR-containing non-viral 
vectors have been used to develop genetically modified pigs 
(Manzini et al., 2006).  
The mitotic stability of S/MAR-episomal vectors is 
achieved via the direct interaction of the S/MAR sequence 
with the scaffold attachment factor A (SAF-A) protein, 
which is a component of the nuclear matrix. Despite its im-
portant functions, the innate functional module of the 
S/MAR sequence was revealed only in 2004, when Andreas 
and colleagues identified a minimal S/MAR sequence, a 
tetramer of a 155-bp module from a natural S/MAR. This 
minimal S/MAR sequence is sufficient for episomal replica-
tion and mitotic stability and can functionally replace the 
more complex and extended original S/MAR sequence 
(Jenke et al., 2004b). The minimal S/MAR sequence greatly 
improves the mitotic stability and cloning capacity of epi-
somal vectors in dividing cells compared with the original 
sequence (Broll et al., 2010).  
In the present study, we incorporated the minimal 
S/MAR sequences from the human -interferon gene cluster 
into non-integrating lentiviral vectors. The resulting mini-
mal S/MAR-based non-integrating lentiviral (SNIL) vectors 
were retained in dividing cells and maintained long-term 
transgene expression. Thus, in the presence of the minimal 
S/MAR sequence, non-integrating lentiviral vectors can 
achieve persistent episomal transgene expression in dividing 
cells, thereby demonstrating the potential of this vector as a 
gene transfer tool.   
RESULTS 
Construction of non-integrating lentiviral vectors based 
on the minimal S/MAR sequence (SNIL)  
The non-integrating lentiviral vectors used in the present 
study were created using a HIV-based self-inactivating len-
tiviral backbone, and they contained an exogenous eGFP 
gene under the control of the human elongation factor 1 
(hEF1) promoter. In minimal S/MAR-containing non- 
integrating lentiviral vectors (termed SNILs), the 720-bp 
minimal S/MAR sequence from the human -interferon 
gene cluster was cloned immediately downstream of the 
eGFP expression cassette to achieve active upstream tran-
scription and ensure the proper functioning of the S/MAR 
sequence (Hagedorn et al., 2011). Non-integrating control 
vectors (termed NIL) were similarly constructed, although 
they lacked the minimal S/MAR sequence (Figure 1).  
Production of non-integrating lentiviruses from SNIL 
vectors 
Minimal S/MAR-containing non-integrating lentiviral vec-
tors and non-S/MAR controls were packaged from the SNIL 
and NIL plasmids, respectively, using the integrase-    
defective packaging plasmid pLV-HELP-NIL and then 
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Figure 1  Lentiviral expression plasmids used in this study. The 
eGFP-expressing lentiviral vectors are based on pLenti6.4/R4R2/V5-DEST, 
in which eGFP expression is driven by the human elongation factor 1 
(hEF1) promoter. A, lentiviral-expressing vector without the minimal 
S/MAR sequence (9,458 bp). B, lentiviral-expressing vector with the 
minimal S/MAR sequence (10,318 bp). 
pseudotyped using the vesicular stomatitis virus glycopro-
tein (VSV-G) envelope protein. The S/MAR-containing 
integrating lentiviral control (termed IL) was also packaged 
from the SNIL plasmid using the integrase-competence 
plasmid pLV-HELP-IN. High-level eGFP expression was 
detected 48 h after transfection of the packaging systems  
into the 293FT cells (Figure S1 in Supporting Information). 
A comparison of the eGFP expression between the SNIL 
and NIL groups demonstrated that the minimal S/MAR se-
quence did not disturb eGFP expression. High-level GFP 
expression typically indicates high-titer lentiviral production. 
The 48-h p24 titer of the S/MAR-containing lentivirus was 
77.905 ng mL1, which is approximately 9.738×108 LP mL1 
(LP: lentiviral particles; 1 ng p24=1.25×107 lentiviral parti-
cles as indicated by the lentivirus titer kit manual). These 
results suggest that the minimal S/MAR sequence does not 
disrupt transgene expression and viral packaging.  
Stable clones are formed in the SNIL/CHO group but 
not in the NIL/CHO group 
CHO cells in logarithmic growth were transduced separate-
ly with non-integrating SNIL and NIL lentiviruses and the 
integrating control IL lentivirus at serial MOIs (multiplici-
ties of infection). After blasticidin selection for 14 days, the 
SNIL group with the minimal S/MAR sequence formed 
stable cell clones (Figure 2) that exhibited eGFP expression. 
However, in the NIL group without the S/MAR sequence, 
stable clones were not formed. The colony-forming effi-
ciency of the SNIL vectors was detected using the colony- 
forming assay. As shown in Figure 3, the colony-forming 
efficiency of the SNIL vector increased as the MOI of the 
corresponding virus increased, and at MOIs of 5 and 10, the 
colony-forming efficiency reached 0.25% and 0.20%, re-
spectively (Table 1).   
Table 1  Colony-forming efficiency of the SNIL vectors at different 
MOIs. Stably transduced CHO clones were stained with crystal violet. The 
clone numbers were counted, and the colony-forming efficiency was cal-
culated using the following formula: colony-forming efficiency=clone 
numbers/number of cells used for vectors transduction × 100%. MOI, 
multiplicity of infection. 





1 400 1.125×106 0.03% 
2 510 1.125×106 0.05% 
5 2,800 1.125×106 0.25% 
10 6,000 3.0×106 0.20% 
 
 
Figure 2  Stable CHO clones generated after 14 days of selection in the SNIL group. Microscopic images of stable clones formed at an MOI of 10 in the 
SNIL group are shown as representatives. Green, eGFP. 
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Figure 3  Colony-forming assay of SNIL-transduced CHO stable clones. CHO cells were infected by SNIL virus at MOIs of 1, 2, 5 and 10 respectively. 
After 14 days’ selection, the stably transduced cell clones formed were stained with crystal violet. The deep violet dots show single stable cell clones. The 
results are representative of two independent experiments. 
SNIL vectors confer persistent transgene expression in 
CHO cells  
After 14 days of selection, all the cells in the NIL groups 
without the S/MAR sequence died under selection. Howev-
er, in the SNIL group with the S/MAR sequence and the 
integrating control IL group, bulk populations were collect-
ed and passaged continuously with or without selection and 
their eGFP expression was detected by FACS analysis at the 
indicated time points. In the SNIL group (Figure 4), eGFP 
expression persisted for 61 days with or without selection. 
More importantly, the eGFP expression patterns were the 
same between the selection group and the non-selection 
group. The S/MAR-containing integrating control IL group 
also showed a sustained eGFP expression as expected, and 
the transducing efficiency was higher in this group than in 
the SNIL groups. Taken together, these results suggest that 
the SNIL vectors retained transgene expression in dividing 
cells in the presence of the minimal S/MAR sequence.  
SNIL vectors are retained extrachromosomally primar-
ily as 1-LTR circular episomes in CHO stable clones 
SNIL vector DNA persists in CHO stable clones 
After detecting the persistent expression of the SNIL vec-
tors in the CHO cells, the presence of the SNIL vector DNA 
was further investigated. A PCR analysis was performed to  
 
 
Figure 4  Time-course analysis of the percentage of eGFP expressed cells 
in CHO stable cells. CHO cells infected with SNIL or IL lentivirus at a 
MOI of 10 were selected as stable cells. Fourteen days later, the bulk pop-
ulations were randomly collected and passaged continuously with or with-
out selection. eGFP expression was detected by FACS analysis at the indi-
cated time points (days after infection). Upper two lines, integrating control 
IL groups; lower two lines, SNIL groups; “+Bla”, with blasticidin selection; 
“Bla”, without blasticidin selection. 
assess the persistence of the SNIL DNA in the CHO stable 
cells. At the FACS detection time points, total DNA was 
extracted from the SNIL- and IL-transduced stable CHO 
clones for use as a PCR template, and the blasticidin-   
resistance (bla) gene sequences present in the backbone of 
the SNIL and IL vectors were then used as expansion pri-
mers. The PCR reactions were analyzed by electrophoresis. 
Figure 5A shows the PCR results at the end of the eGFP 
expression experiment (i.e., the PCR template was DNA 
from stably transduced cells that had undergone 61 days of 
selection). Both the SNIL and IL groups were positive for 
the 337-bp bands, confirming that the SNIL vector DNA 
was present in the CHO stable cells after 61 days of trans-
duction and selection, which is similar to the integration 
control of the IL vector. 
SNIL vector is primarily retained as a 1-LTR circular epi-
some in CHO stable cells 
After entry into cells, the non-integrating lentiviral vectors 
primarily exist in two circular forms: 1-LTR and 2-LTR 
episomes, which indicate the episomal status of these vec-
tors. The presence of the circular molecules reflects the ep-
isomal existence of non-integrating lentiviral vectors. 
c2LTR PCR is a popular method for detecting these two 
circular molecules (Vargas et al., 2004).   
As shown in Figure 5B, the primers designed for the re-
gion crossing the circulation joint area amplified only cir-
cular DNA and not integrated DNA. Total DNA was ex-
tracted from the SNIL and IL control groups after 61 days 
of selection and used as templates for the c2LTR PCR as-
say. The PCR products were separated on an agarose gel, 
and the results (Figure 5C) indicated that two circular forms 
of the vectors in the SNIL group occurred at different con-
centrations. Further sequencing ((Figure S2 and Table S1 in 
Supporting Information) of the major band in the SNIL 
group revealed that this band corresponded to the 1-LTR 
circle (c1-LTR) DNA, which suggested that the SNIL vec-
tor was primarily retained as a c1-LTR circular form in the 
CHO clones. This result is consistent with previous reports 
showing that c1-LTR is present at a higher concentration 
than the c2-LTR form in non-integrating lentivi-
ral-transduced cells (Banasik and McCray, 2010; Farnet and 
Haseltine, 1991; Pauza et al., 1994).   
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Figure 5  PCR analysis of the presence of vector DNA in CHO stable cells after 61 days of selection. An electrophoresis map of the PCR products is shown. 
A, Blasticidin gene PCR results. The 337-bp positive bands are indicated with arrows. B, Primer design for the c2LTR PCR. The arrows show the binding 
sites of the primers on the 1/2-LTR circular forms. C, c2LTR PCR results. Total DNA was extracted from SNIL- and IL-infected CHO stable cells, and   
40 ng of each sample was used as a template for the c2LTR PCR. Two PCR reactions were performed in parallel using the c2LTR PCR primers (left) or 
GAPDH primers (right). CHO stable cells infected with SNIL and the IL control (both at a MOI of 10) were detected. Left: results obtained with the c2LTR 
primers; the arrow indicates the 1-LTR circular DNA bands. Right: results obtained with the GAPDH primers; the arrow shows a 435-bp PCR product for 
GAPDH. Mock, uninfected CHO cells; Blank, PCR control with no template; M, DL2000. 
LTR circles were also detected in the IL group (Figure 
5C), although they may have been lost during cell division 
because of the lack of an origin of replication. Here, the 
integrating control IL vectors also carried a minimal 
S/MAR sequence, which prolonged the existence of the 
circular LTR forms in a manner similar to that of the SNIL 
vector group.  
SNIL vectors are retained extrachromosomally in CHO 
cells 
Southern blot is a traditional method of detecting the status 
of DNA molecules in cell nuclei. Therefore, a Southern blot 
analysis was performed in this study to detect the status of 
the SNIL vector, and the results are shown in Figure 6.  
The Southern probe was a 337-bp blasticidin-resistance 
gene on the SNIL/IL vector backbone that does not have a 
homologous sequence in the CHO genome. BamH I was 
used to digest the samples for the Southern blot analysis. 
The BamH I-linearized packaging plasmid pLenti-hEF1- 
eGFP-sSMAR that was added to the mock CHO genome in 
serial copy numbers was detected in parallel with the SNIL 
and IL groups, which function as a system control. As 
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Figure 6  Southern blot detection of vector DNA present in CHO stable cells. After 61 days of eGFP expression detection, a Southern blot assay was per-
formed to detect the status of the vector DNA in the CHO stable cells. A 337-bp blasticidin-resistance gene on the SNIL/IL vector backbone that does not 
have a homologous sequence in the CHO genome was used as a probe to perform the Southern blot detection. A, Illustration of the circular form and BamH I- 
linearized form of the SNIL episomal vector. B, Illustration of the integrated form of IL vector. C, Southern blot results. Left: M, DNA marker; Blank, total 
DNA of un-transduced CHO cells; SNIL, total DNA of SNIL-transduced CHO cells. IL, total DNA of IL-transduced CHO cells. Right, BamH I-linearized 
packaging plasmid pLenti-hEF1a-eGFP-sSMAR added to the mock CHO genome in the indicated copy numbers as a control. 
shown in Figure 6C (right), a single 9,778-bp positive band 
was detected in the system control lanes, and the intensity 
of the positive band increased as the copy number of the 
plasmid increased. This result suggests that the probe used 
is specific for the Southern blot analysis.  
If the SNIL vector occurs as an episome in CHO stable 
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cells, linearization by BamH I should produce a single 
6,532-bp band (illustrated in Figure 6A). If the SNIL vector 
integrates into the genome, several different-sized bands 
should be observed after thorough digestion by BamH I 
because of random integration (illustrated in Figure 6B). 
The Southern blot results in Figure 6C (left) showed that 
there were several different-sized bands present in the IL 
group, whereas only one specific band was observed in the 
SNIL group, indicating that the SNIL vector is present in an 
episomal form in CHO stable cells. 
DISCUSSION 
Despite the mitotic stability and efficient gene delivery of 
non-dividing systems, NIL vectors are lost in dividing cells 
because of rapid cell proliferation, which limits the use of 
NIL vectors in dividing systems. Here, we combined a 
non-integrating lentiviral vector with the core element of 
episomal vectors, the minimal S/MAR sequence from the 
human -interferon locus. After 14 days of selection, all the 
transduced cells died under selection in the NIL groups 
without the S/MAR sequence, whereas with the presence of 
the S/MAR sequence, the non-integrating SNIL group ex-
hibited persistent eGFP expression for 61 days. More im-
portantly, the eGFP expression patterns were the same be-
tween the selection and non-selection groups during the 
detection period. Many attempts have been made to modify 
NIL vectors to expand their application in dividing cells. In 
2004, Vargas and colleagues reported an NIL vector capa-
ble of conditionally replicating in dividing cells. The au-
thors inserted the origin of replication sequence from the 
SV40 promoter (SV40 ori) into NIL vectors and detected 
active transcription and episomal persistence in dividing 
cells expressing the large T antigen (Tag) (Farnet and 
Haseltine, 1991). This conditional replication still limits the 
vector’s usage, and the incorporation of the SV40 ori se-
quence and Tag protein also raises safety issues. The SV40 
ori is virus derived, and the Tag protein is a tumor antigen. 
These elements could induce cell transformation, activate 
the host immune response or even induce tumorigenesis 
(Fried, 1965; Moens et al., 1997; Slinskey et al., 1999). 
Moreover, this system generates 28 days of transgene ex-
pression, and only 20%–29% of the cells are positive for 
GFP expression; therefore, the efficiency is not sufficient. 
In the present study, the minimal S/MAR sequence in the 
SNIL vector enabled the sustained expression of eGFP for 
61 days, and this expression was detected in approximately 
40% of the cells. 
Verghese et al. reported the performance of the aniLV 
vector, a NIL vector containing the original 2.1-kb S/MAR 
sequence (Verghese et al., 2014). The authors used the 
original long S/MAR sequence and detected persistent GFP 
expression for 56 days, although GFP expression was de-
tected only in 10% of the aniLV stably transduced cells. In 
the present study, eGFP expression persisted for 61 days 
with or without selection and this expression was detected 
in approximately 40% of the SNIL stably transduced cells 
(Figure 4). Thus, compared with the original 2.1-kb S/ 
MAR-containing aniLV vector, the efficiency of the 720-bp 
minimal S/MAR vector was much higher.  
The minimal S/MAR sequence is a tetramer of a 155-bp 
module from the natural 2.1-kb S/MAR (Bode et al., 1992) 
and a 25-bp linker (Jenke et al., 2004b) and reportedly has 
the same episomal function as the 2.1-kb sequence. This 
minimal S/MAR associates with the nuclear matrix by in-
teracting with the SAF-A protein and is stabilized during 
mitosis (Jenke et al., 2004b). In the present study, the use of 
the minimal S/MAR sequence instead of the natural longer 
sequence reduces the vector size and greatly facilitates vec-
tor manipulation. Most importantly, the small-sized vector 
is likely to be packaged more efficiently to generate high- 
titer viral particles, which will ultimately result in high gene 
transfer efficiency. The shortened S/MAR sequence also 
leaves more space for exogenous genes, which is a vital 
feature for efficient gene transfer vectors. 
Furthermore, the present study demonstrated that the 
vector efficiency increased as the MOI of the lentivirus in-
fection increased, indicating the flexibility of the SNIL 
vector system: transgene expression could easily be adjust-
ed to the desired level by changing the MOI of the SNIL 
virus, thereby satisfying the various needs for therapeutic 
gene expression in gene therapy trials.   
In conclusion, the present study demonstrates for the first 
time that the inclusion of the minimal S/MAR sequence 
efficiently retains the episomal transgene expression of the 
NIL vectors in dividing cells. Therefore, this novel SNIL 
vector has the potential for use as a tool in gene addition 
therapies for diseases caused by functional gene defects in 
which the expression of the functional protein could provide 
a selective advantage and increase the efficiency of the 
vector. However, prior to the clinical use of this vector, fur-
ther studies should be performed to examine the effects of 
replacing the eGFP gene with therapeutic genes and deter-
mine the overall underlying epigenetic regulation of these 
vectors in the nucleus. 
MATERIALS AND METHODS 
Minimal S/MAR sequence  
The minimal S/MAR sequence used in this study is a 
720-bp tetramer of the 155-bp module from the human 
-interferon S/MAR sequence, as previously reported 
(Jenke et al., 2004b). This minimal S/MAR sequence was 
commercially synthesized with NotI restriction sites on both 
ends (Invitrogen, USA).  
Construction of lentiviral expression plasmids 
The HIV-1-based lentiviral expression plasmids were con-
structed based on the commercially available plasmid pLen-
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ti6.4/R4R2/V5-DEST (Invitrogen, USA). The entire 
hEF1-GFP expression cassette was PCR amplified from 
the pEPI-hEF1-GFP plasmid (maintained in our lab) using 
the following primers: upper, 5′-CGTGAGGCTCCGGTGC 
CCGT-3′; and lower, 5′-TCATTACTTGTACAGCTCGTC 
ATGCCG-3′. The hEF1-GFP cassette, alone or together 
with the minimal S/MAR sequence, was cloned into pLen-
ti6.4/R4R2/V5-DEST using the Multisite Gateway LR re-
combination kit (Invitrogen, USA) according to the manu-
facturer’s instructions to generate lentiviral expression 
plasmids without or with the minimal S/MAR sequence, 
respectively. These lentiviral expression plasmids were used 
with the helper plasmids pLV-VSV-G (Burns et al., 1993) 
(encoding vesicular stomatitis viral envelope glycoprotein) 
and pLV-HELP-IN or pLV-HELP-NIL (coding HIV-1 
Gag-Pol) to generate integrating or non-integrating virus 
particles (Leavitt et al., 1996), respectively. The helper 
plasmids were purchased from InvivoGen.  
Cell culture 
293FT and CHO cells were grown in Dulbecco’s modified 
Eagle medium supplemented with 10% fetal bovine serum 
and 1% Pen/Strep. The 293FT cells were additionally sup-
plemented with 4 mmol L1 L-glutamine, 0.1 mmol L1 
MEM non-essential amino acids (NEAA) and 1 mmol L1 
MEM sodium pyruvate. All of the media and reagents were 
obtained from Invitrogen. The cell lines were confirmed by 
the China Infrastructure of Cell Line Resources. 
Lentiviral vector production and titer assay  
The 293FT cells were seeded at a density of 5×106 cells 
onto 10-cm tissue culture dishes (Corning, USA). The viral 
stocks were produced by the transient transfection of 293FT 
cells with the following three packaging plasmids: lentiviral 
expression plasmids with or without the minimal S/MAR 
sequence and the helper plasmids pLV-VSV-G and pLV- 
HELP. The integrating viral stocks were generated using 
pLV-HELP-IN, which encodes a competent integrase, and 
the non-integrating viral stocks were obtained using 
pLV-HELP-NIL, which carries a D64V mutation encoding 
a defective integrase. The 293FT cells were transfected at 
95% confluence using the Lipofectamine 2000 transfection 
reagent (Invitrogen, USA) according to the manufacturer’s 
instructions. The vector supernatant was harvested at 48 h 
post-transfection, filtered through a 0.45-μm filter and con-
centrated using PEG-it Virus Precipitation Solution (System 
Biosciences, SBI, USA) according to the manufacturer’s 
instructions. The viral pellet was resuspended in DMEM for 
immediate use or divided into aliquots and stored at 80°C.  
As mentioned in the Introduction section, the S/MAR 
sequence reportedly enhances gene expression (Jenke et al., 
2002). eGFP expression in target cells may be influenced by 
the presence/absence of the S/MAR sequence; therefore, it 
could not be used to accurately reflect titer differences be-
tween the groups in our study. The p24 titer method used in 
this research detected only the lentivirus-associated p24 and 
not the total p24. The lentivirus-associated p24 titer is the 
lentivirus physical titer and not the infection titer. Based on 
previous studies (Yáñez-Muñoz, 2006), lentivirus-associ- 
ated p24 can be used to balance the virus usage in diferent 
experimental groups. According to the instructions for the 
lentiviral vectors (ViraPower™ HiPerform™ Promoterless 
Gateway® Expression System), MOI=lentiviral particle/cell 
number. The lentiviral particle was calculated using the 
following formula: 1 ng of p24=1.25×107 LPs (Quick-
Titer™ Lentivirus Titer Kit Lentivirus-Associated HIV 
p24). In conclusion, the MOI was primarily calculated using 
the following two formulas: 1 ng p24=1.25×107 LPs and 
MOI=lentiviral particle/cell number. 
Cell transduction and stable cell line selection 
The CHO cells were transduced at 30%–40% confluence 
with lentiviral particles in the presence of 8 μg mL1 
polybrene (Sigma-Aldrich, USA). Four hours later, the 
transduction medium was removed and replaced with fresh 
medium. The following day, 5 μg mL1 blasticidin was 
added to the cell medium to select stably transduced cell 
lines. The transduced cells were continuously cultured un-
der these conditions for 14 days. Next, the stable cell clones 
were all gathered as bulk populations. These stable cell 
clones were cryopreserved for subsequent study.    
Colony-forming assay 
When stable cell clones were formed, the culture medium 
was removed, and the clones were rinsed twice with PBS. 
Next, 5 mL of fixing and staining solution was added (6% 
glutaraldehyde and 0.5% crystal violet), and the clones were 
stained at room temperature for 30 min. The fixing and 
staining solution was removed after staining, and the clones 
were then rinsed with tap water and air dried. The clones 
containing more than 50 cells were counted to calculate the 
colony-forming efficiency. 
Flow cytometry 
At the designated time points, 25% of the cells were har-
vested to detect eGFP expression by flow cytometry using a 
FACSCalibur instrument (BD Accuri C6, BD Biosciences, 
USA). More than 10,000 events were recorded for any giv-
en experiment. Data acquisition and analysis were per-
formed using CFlow Plus software (BD Biosciences).  
Polymerase chain reaction 
A polymerase chain reaction (PCR) assay was used to de-
tect the presence of vector DNA in the stably transduced 
CHO clones. Total DNA was extracted from stable clones 
using the Wizard Genomic DNA purification kit (Promega, 
USA). A 25-µL PCR reaction containing DNA template, 
1×Taq PCR buffer, 200 μmol L1 dNTPs, 0.2 μmol L1 pri-
mers and 1 U of Taq polymerase (Fermentas-Thermo Fisher 
1032 Xu, Z., et al.   Sci China Life Sci   October (2016) Vol.59 No.10 
Scientific, USA) was used. The following primer sequences 
were used: bla upper, 5′-AGAGCAACGGCTACAAT- 
CAACA-3′; and bla lower, 5′-CAGAGGGCAGCAATTCA 
CG-3′. The PCR conditions were as follow: denaturing at 
95°C for 5 min; 30 cycles of denaturation at 95°C for 30 s, 
annealing at 56.8°C for 30 s, and elongation at 72°C for  
21 s; terminal elongation at 72°C for 10 min; and holding at 
4°C. The reactions were analyzed by agarose electrophoresis. 
c2LTR PCR 
c2LTR PCR is similar to a typical PCR reaction, except for 
the amount of template used and the application of special 
c2LTR PCR primers: 40 ng of total DNA from each sample 
was used as a template, and the c2LTR PCR primer se-
quences were 5′-CCTGGGATCAAAGCCATAGTG (up-
per) and 5′-CAAGCCGAGTCCTGCGTC (lower), and the 
Tm was 55.2°C. The housekeeping gene GAPDH was also 
amplified in the c2LTR PCR as an internal control using the 
primer sequences 5′-GGTCGGCGTGAACGGATTTGG- 
CCG (upper) and 5′-CGCATTGCTGACAATCTTGAG- 
GGAG (lower) and a Tm of 58.5°C.  
Southern blot analysis  
Total DNA was extracted from the stable cell clones using 
the Wizard Genomic DNA purification kit (Promega, USA) 
and digested with BamH I. Ten micrograms of enzyme-  
digested DNA was separated on a 0.8% agarose gel      
(1.5 V cm1) and then transferred to a positively charged 
nylon membrane (GE, USA) according to the manufactur-
er’s instructions. A 337-bp blasticidin-resistance gene pre-
sent in the backbones of all lentiviral vectors used in this 
study was PCR amplified from the plenti-hEF1-eGFP- 
sSMAR plasmid and labeled with 32P (Radom Primer DNA 
labelling kit, TaKaRa, Japan). The blotted DNA was then 
hybridized with the 32P-labeled probe at 65°C for 2 h in 
Amersham Rapid-hyb buffer (GE, USA), which was fol-
lowed by thoroughly washing using SSC solution according 
to the manufacturer’s instructions. Finally, the membrane 
was placed face down on a film at 80°C for 1 to 2 days. 
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